-

Naman Sharma1, Giuseppe G Loscocco2,3, Naseema Gangat2

  • 1Department of Hematology and Oncology, University of Massachusetts-Baystate Medical Center, Springfield, MA, USA.

Leukemia & lymphoma
|November 14, 2024
PubMed
概括

全基性造血干细胞移植 (AHSCT) 提供了治疗髓纤维化 (MF) 的方法. 尽管结果有所改善,但像GVHD这样的风险仍然存在,但替代捐赠者现在更安全,扩大了MF患者的获取.